Celgene Investor
Celgene discovers, develops and commercializes innovative therapies to treat cancer and immune-inflammatory-related diseases.
Invests into
%20.jpg)
%20.jpg)
Acquisitions Number:
Made Acquisitions, Was Acquired
Founded Date:
1986-01-01
Headquarters:
Summit, New Jersey, United States
Investors Number:
65
Technology:
Pharma
Employee Number:
8.85K
Industry:
Biotechnology, Medical
Estimated Revenue:
$10B+
Number Of Exists:
31
Funding Status:
M&A
Investor Type:
Not Classified